Richard van der Maazen

Early Positron Emission Tomography Response–Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial

Marc André, T. Girinsky, Massimo Federico et al. · Journal of Clinical Oncology · 2017 · 532 citations · Full text

Medicine, Oncology, Pharmacology +17

Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma

Frederika A. van Nimwegen, Michael Schaapveld, David J. Cutter et al. · Journal of Clinical Oncology · 2015 · 458 citations

Medicine, Oncology, Radiation Oncology +17

Omitting Radiotherapy in Early Positron Emission Tomography–Negative Stage I/II Hodgkin Lymphoma Is Associated With an Increased Risk of Early Relapse: Clinical Results of the Preplanned Interim Analysis of the Randomized EORTC/LYSA/FIL H10 Trial

John Raemaekers, Marc André, Massimo Federico et al. · Journal of Clinical Oncology · 2014 · 383 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: Concepts and guidelines

T. Girinsky, Richard van der Maazen, Lena Specht et al. · Radiotherapy and Oncology · 2006 · 374 citations

Medicine, Oncology, Radiation Oncology +9

The conundrum of hodgkin lymphoma nodes: To be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines

T. Girinsky, Lena Specht, Mithra Ghalibafian et al. · Radiotherapy and Oncology · 2008 · 112 citations

Medicine, Oncology, Radiation Oncology +15